Retraction Note: Dose-dependent changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation [BMC Neurosci. 13, (2012)(50)] DOI: 10.1186/1471-2202-13-50;Dose-dependent changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation

BMC Neuroscience

Volumn 13, Issue 1, 2012, Pages

  Kellom, Matthew ^a   Basselin, Mireille ^a   Keleshian, Vasken L ^a   Chen, Mei ^a   Rapoport, Stanley I ^a   Rao, Jagadeesh S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Arachidonic acid; Cytokine; Drebrin; Lipopolysaccharide; Neuroinflammation; NF B; Phospholipase A2; Synapse; Synaptophysin

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CYCLOOXYGENASE 2; DREBRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2 GROUP IV; PHOSPHOLIPASE A2 GROUP V; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN P50; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOSOLIC PHOSPHOLIPASE A2; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; SECRETORY PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; MALE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; 5 LOX GENE; ANIMAL MODEL; ASTROCYTE; COX 2 GENE; CPLA2 GENE; ENZYME PHOSPHORYLATION; FATTY ACID METABOLISM; MICROGLIA; PROTEIN DNA BINDING; SPLA2 GENE; WEIGHT REDUCTION;

EID: 84861335001     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/s12868-017-0360-5     Document Type: Erratum

References (69)

1. Anthony IC, Bell JE. The Neuropathology of HIV/AIDS. Int Rev Psychiatry 2008, 20(1):15-24. 10.1080/09540260701862037, 18240059.
2. Esposito G, Giovacchini G, Liow JS, Bhattacharjee AK, Greenstein D, Schapiro M, Hallett M, Herscovitch P, Eckelman WC, Carson RE, et al. Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. J Nucl Med 2008, 49(9):1414-1421. 10.2967/jnumed.107.049619, 2587283, 18703605.
3. Nimmo AJ, Vink R. Recent patents in CNS drug discovery: the management of inflammation in the central nervous system. Recent Pat CNS Drug Discov 2009, 4(2):86-95. 10.2174/157488909788452997, 19519558.
4. Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 2010, 15(4):384-392. 10.1038/mp.2009.47, 2844920, 19488045.
5. Richardson RL, Kim EM, Gardiner T, O'Hare E. Chronic intracerebroventricular infusion of lipopolysaccharide: effects of ibuprofen treatment and behavioural and histopathological correlates. Behav Pharmacol 2005, 16(7):531-541. 10.1097/01.fbp.0000179278.03868.96, 16170230.
6. Rosenberger TA, Villacreses NE, Hovda JT, Bosetti F, Weerasinghe G, Wine RN, Harry GJ, Rapoport SI. Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J Neurochem 2004, 88(5):1168-1178. 10.1046/j.1471-4159.2003.02246.x, 15009672.
7. Basselin M, Villacreses NE, Lee HJ, Bell JM, Rapoport SI. Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. J Neurochem 2007, 102(3):761-772. 10.1111/j.1471-4159.2007.04593.x, 17488274.
8. Basselin M, Kim HW, Chen M, Ma K, Rapoport SI, Murphy RC, Farias SE. Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation. J Lipid Res 2010, 51(5):1049-1056. 10.1194/jlr.M002469, 2853431, 20040630.
9. Basselin M, Ramadan E, Chen M, Rapoport SI. Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites. Neurochem Res 2011, 36(1):139-145. 10.1007/s11064-010-0282-4, 3011042, 20981485.
10. Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res 1998, 780(2):294-303. 10.1016/S0006-8993(97)01215-8, 9507169.
11. Willard LB, Hauss-Wegrzyniak B, Danysz W, Wenk GL. The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition. Exp Brain Res 2000, 134(1):58-65. 10.1007/s002210000446, 11026726.
12. Marriott LK, McGann-Gramling KR, Hauss-Wegrzyniak B, Sheldahl LC, Shapiro RA, Dorsa DM, Wenk GL. Estrogen replacement regimen and brain infusion of lipopolysaccharide differentially alter steroid receptor expression in the uterus and hypothalamus. Endocrine 2007, 32(3):317-328. 10.1007/s12020-008-9038-1, 18247162.
13. Hauss-Wegrzyniak B, Wenk GL. Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle. Neurosci Lett 2002, 322(2):75-78. 10.1016/S0304-3940(02)00087-3, 11958847.
14. Kojima N, Kato Y, Shirao T, Obata K. Nucleotide sequences of two embryonic drebrins, developmentally regulated brain proteins, and developmental change in their mRNAs. Brain Res 1988, 464(3):207-215.
15. Aoki C, Sekino Y, Hanamura K, Fujisawa S, Mahadomrongkul V, Ren Y, Shirao T. Drebrin A is a postsynaptic protein that localizes in vivo to the submembranous surface of dendritic sites forming excitatory synapses. J Comp Neurol 2005, 483(4):383-402. 10.1002/cne.20449, 15700273.
16. Ivanov A, Esclapez M, Pellegrino C, Shirao T, Ferhat L. Drebrin A regulates dendritic spine plasticity and synaptic function in mature cultured hippocampal neurons. J Cell Sci 2009, 122(Pt 4):524-534.
17. Evans GJ, Cousin MA. Tyrosine phosphorylation of synaptophysin in synaptic vesicle recycling. Biochem Soc Trans 2005, 33(Pt 6):1350-1353. 2077014, 16246116.
18. El-Husseini AE, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS. PSD-95 involvement in maturation of excitatory synapses. Science 2000, 290(5495):1364-1368.
19. Harigaya Y, Shoji M, Shirao T, Hirai S. Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease. J Neurosci Res 1996, 43(1):87-92. 10.1002/jnr.490430111, 8838578.
20. Kellom M, Basselin M, Chen M, Rapoport SI, Rao JS. Increased neuroinfl ammatory and arachidonic acid cascade markers with synaptic marker loss in lipopolysaccharide infused rats. FASEBJ 2011, 25(650):1-15.
21. DeMar JC, Lee HJ, Ma K, Chang L, Bell JM, Rapoport SI, Bazinet RP. Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim Biophys Acta 2006, 176(9):1050-1059.
22. Rosenberger TA, Villacreses NE, Weis MT, Rapoport SI. Rat brain docosahexaenoic acid metabolism is not altered by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. Neurochem Int 2010, 56(3):501-507. 10.1016/j.neuint.2009.12.010, 2828881, 20026368.
23. Hauss-Wegrzyniak B, Lukovic L, Bigaud M, Stoeckel ME. Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Res 1998, 794(2):211-224. 10.1016/S0006-8993(98)00227-3, 9622633.
24. Lahiri DK. An region upstream of the gene promoter for the beta-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells. Brain Res Mol Brain Res 1998, 58(1-2):112-122.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
26. Ford AL, Goodsall AL, Hickey WF, Sedgwick JD. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J Immunol 1995, 154(9):4309-4321.
27. Possel H, Noack H, Putzke J, Wolf G, Sies H. Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia 2000, 32(1):51-59. 10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4, 10975910.
28. Ooe N, Saito K, Mikami N, Nakatuka I, Kaneko H. Identification of a novel basic helix-loop-helix-PAS factor, NXF, reveals a Sim2 competitive, positive regulatory role in dendritic-cytoskeleton modulator drebrin gene expression. Mol Cell Biol 2004, 24(2):608-616. 10.1128/MCB.24.2.608-616.2004, 343817, 14701734.
29. Lietz M, Hohl M, Thiel G. RE-1 silencing transcription factor (REST) regulates human synaptophysin gene transcription through an intronic sequence-specific DNA-binding site. Eur J Biochem 2003, 270(1):2-9.
30. Sa MJ, Madeira MD, Ruela C, Volk B, Mota-Miranda A, Paula-Barbosa MM. Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study. Acta Neuropathol 2004, 107(2):97-110. 10.1007/s00401-003-0781-3, 14605830.
31. Griffin DE, Wesselingh SL, McArthur JC. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 1994, 35(5):592-597. 10.1002/ana.410350513, 7910004.
32. Wesselingh SL, Glass J, McArthur JC, Griffin JW, Griffin DE. Cytokine dysregulation in HIV-associated neurological disease. Adv Neuroimmunol 1994, 4(3):199-206. 10.1016/S0960-5428(06)80258-5, 7874388.
33. Hatanpaa K, Isaacs KR, Shirao T, Brady DR, Rapoport SI. Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. J Neuropathol Exp Neurol 1999, 58(6):637-643. 10.1097/00005072-199906000-00008, 10374754.
34. Abelev BI, Aggarwal MM, Ahammed Z, Amonett J, Anderson BD, Anderson M, Arkhipkin D, Averichev GS, Bai Y, Balewski J, et al. Longitudinal double-spin asymmetry and cross section for inclusive jet production in polarized proton collisions at square root of s = 200 GeV. Phys Rev Lett 2006, 97(25):1-25.
35. Kim HW, Rapoport SI, Rao JS. Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis 2009, 37(3):596-603. 2823851, 19945534.
36. Rapoport SI. Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostaglandins, leukotrienes, and essential fatty acids 2008, 79(3-5):153-156.
37. Cole GM, Frautschy SA. DHA may prevent age-related dementia. J Nutr 2010, 140(4):869-874. 10.3945/jn.109.113910, 2838628, 20181786.
38. Coulon L, Calzada C, Moulin P, Vericel E, Lagarde M. Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets. Free Radic Biol Med 2003, 35(6):616-625. 10.1016/S0891-5849(03)00386-1, 12957654.
39. Sawada M, Suzumura A, Hosoya H, Marunouchi T, Nagatsu T. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J Neurochem 1999, 72(4):1466-1471.
40. Balsinde J, Shinohara H, Lefkowitz LJ, Johnson CA, Balboa MA, Dennis EA. Group V phospholipase A(2)-dependent induction of cyclooxygenase-2 in macrophages. J Biol Chem 1999, 274(37):25967-25970. 10.1074/jbc.274.37.25967, 10473537.
41. Strokin M, Sergeeva M, Reiser G. Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br J Pharmacol 2003, 139(5):1014-1022. 10.1038/sj.bjp.0705326, 1573920, 12839876.
42. Czapski GA, Gajkowska B, Strosznajder JB. Systemic administration of lipopolysaccharide induces molecular and morphological alterations in the hippocampus. Brain Res 2010, 1356:85-94.
43. Serio KJ, Reddy KV, Bigby TD. Lipopolysaccharide induces 5-lipoxygenase-activating protein gene expression in THP-1 cells via a NF-kappaB and C/EBP-mediated mechanism. Am J Physiol Cell Physiol 2005, 288(5):C1125-C1133. 10.1152/ajpcell.00296.2004, 15625306.
44. Vervoordeldonk MJ, Pineda Torra IM, Aarsman AJ, van den Bosch H. Aspirin inhibits expression of the interleukin-1beta-inducible group II phospholipase A2. FEBS Lett 1996, 397(1):108-112. 10.1016/S0014-5793(96)01148-9, 8941724.
45. Hernandez M, Fuentes L, Fernandez Aviles FJ, Crespo MS, Nieto ML. Secretory phospholipase A(2) elicits proinflammatory changes and upregulates the surface expression of fas ligand in monocytic cells: potential relevance for atherogenesis. Circ Res 2002, 90(1):38-45. 10.1161/hh0102.102978, 11786516.
46. Antonio V, Brouillet A, Janvier B, Monne C, Bereziat G, Andreani M, Raymondjean M. Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors. Biochem J 2002, 368(Pt 2):415-424. 1223003, 12188923.
47. Morri H, Ozaki M, Watanabe Y. 5'-flanking region surrounding a human cytosolic phospholipase A2 gene. Biochem Biophys Res Commun 1994, 205(1):6-11. 10.1006/bbrc.1994.2621, 7999086.
48. Kleinert H, Schwarz PM, Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 2003, 384(10-11):1343-1364.
49. Tanabe T, Tohnai N. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 2002, 68-69:95-114. 2844927, 19545642.
50. Maitra U, Gan L, Chang S, Li L. Low-dose endotoxin induces inflammation by selectively removing nuclear receptors and activating CCAAT/enhancer-binding protein delta. J Immunol 2011, 186(7):4467-4473. 10.4049/jimmunol.1003300, 21357541.
51. Pereira SG, Oakley F. Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol 2008, 40(8):1425-1430. 10.1016/j.biocel.2007.05.004, 17693123.
52. Niederberger E, Schmidtko A, Gao W, Kuhlein H, Ehnert C, Geisslinger G. Impaired acute and inflammatory nociception in mice lacking the p50 subunit of NF-kappaB. Eur J Pharmacol 2007, 559(1):55-60. 10.1016/j.ejphar.2006.11.074, 17217946.
53. Campbell J, Ciesielski CJ, Hunt AE, Horwood NJ, Beech JT, Hayes LA, Denys A, Feldmann M, Brennan FM, Foxwell BM. A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis. J Immunol 2004, 173(11):6928-6937.
54. Doza YN, Cuenda A, Thomas GM, Cohen P, Nebreda AR. Activation of the MAP kinase homologue RK requires the phosphorylation of Thr-180 and Tyr-182 and both residues are phosphorylated in chemically stressed KB cells. FEBS Lett 1995, 364(2):223-228. 10.1016/0014-5793(95)00346-B, 7750576.
55. Nakajima K, Tohyama Y, Kohsaka S, Kurihara T. Protein kinase C alpha requirement in the activation of p38 mitogen-activated protein kinase, which is linked to the induction of tumor necrosis factor alpha in lipopolysaccharide-stimulated microglia. Neurochem Int 2004, 44(4):205-214. 10.1016/S0197-0186(03)00163-3, 14602083.
56. Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM, Vogel SN. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 2001, 166(1):574-581.
57. Bhat NR, Fan F. Adenovirus infection induces microglial activation: involvement of mitogen-activated protein kinase pathways. Brain Res 2002, 948(1-2):93-101.
58. Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, Hanisch UK. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 2005, 50(3):235-246. 10.1002/glia.20173, 15739188.
59. Hanisch UK. Microglia as a source and target of cytokines. Glia 2002, 40(2):140-155. 10.1002/glia.10161, 12379902.
60. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ, Vartanian T. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 2002, 22(7):2478-2486.
61. Wright SD, Jong MT. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J Exp Med 1986, 164(6):1876-1888. 10.1084/jem.164.6.1876, 2188477, 3537192.
62. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 1998, 57(1):1-9.
63. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005, 76(2):77-98. 10.1016/j.pneurobio.2005.06.004, 16081203.
64. Li Y, Liu L, Barger SW, Griffin WS. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 2003, 23(5):1605-1611.
65. Munoz L, Ralay Ranaivo H, Roy SM, Hu W, Craft JM, McNamara LK, Chico LW, Van Eldik LJ, Watterson DM. A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. J Neuroinflammation 2007, 4:21. 10.1186/1742-2094-4-21, 2014744, 17784957.
66. Maezawa I, Nivison M, Montine KS, Maeda N, Montine TJ. Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK. FASEB J 2006, 20(6):797-799.
67. Fiebich BL, Schleicher S, Spleiss O, Czygan M, Hull M. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J Neurochem 2001, 79(5):950-958.
68. Goralski KB, Abdulla D, Sinal CJ, Arsenault A, Renton KW. Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation. Am J Physiol Gastrointest Liver Physiol 2005, 289(3):G434-G443. 10.1152/ajpgi.00562.2004, 15878984.
69. Hauss-Wegrzyniak B, Willard LB, Del Soldato P, Pepeu G, Wenk GL. Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Res 1999, 815(1):36-43. 10.1016/S0006-8993(98)01081-6, 9974120.